“The 40-Gene Expression Profile Test Identifies Patients With National Comprehensive Cancer Network High-Risk Cutaneous Squamous Cell Carcinoma at High Risk of Poor Outcomes to Inform Management Decisions”. SKIN The Journal of Cutaneous Medicine 9, no. 4 (July 23, 2025): 2426–2443. Accessed February 1, 2026. https://skin.dermsquared.com/skin/article/view/3561.